Dermatology - European Medical Journal

Continue

Dermatology

Filter
6 Mins
12 Dec 2019

IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance

The symposium “IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance” took place during the 2019 annual European Academy of Dermatology…
10 Mins
12 Dec 2019

Latest Highlights from Guselkumab in Psoriasis from EADV 2019

Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.
10 Mins
12 Dec 2019

Management of Moderate-to-Severe Atopic Dermatitis in the Era of Targeted Treatments

Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…
9 Mins
26 Nov 2019

Psoriasis and Atopic Dermatitis: Addressing Therapeutic Paradigms by Learning from Each Other

Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…
9 Mins
26 Nov 2019

Editor's Pick: Acne Therapy Across Time in the USA

Acne is the most common skin condition in the USA, affecting over half of its population.1 It is an inflammatory skin disease that predominantly…
10 Mins
26 Nov 2019

Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review

Atopic dermatitis (AD) is one of the most common and debilitating chronic inflammatory skin diseases, often greatly affecting physical, economical…
9 Mins
26 Nov 2019

Considering Tomorrow in Today’s Treatment Choice of Women Living with Psoriasis

The objectives of this symposium were to understand the importance of planning treatment addressing the specific needs of women living…
9 Mins
26 Nov 2019

Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases

Type 2 immunity evolved from a dialogue between the immune system and microbes. This form of immunity confers protection against bacteria, viruses…
We’ve noticed you’re accessing
from North/South America.